Forum: Private hospitals should flag medication price hikes, cheaper options
Sign up now: Get ST's newsletters delivered to your inbox
I recently discovered a substantial increase in the price of medication prescribed by a specialist at a private hospital.
In May 2026, I paid $15.23 for a bottle of mometasone nasal spray containing 140 doses. When I returned to the same hospital in November, I was charged $64 for two bottles bearing the same medication description on my invoice, equivalent to $32 per bottle.
I recognise that private hospitals operate commercially and that medication prices may change due to procurement costs, suppliers and other factors. For patients managing chronic conditions, the cumulative cost of medication can be significant. They should not have to compare prices across pharmacies after every specialist consultation simply to avoid unexpected increases.
Commercial considerations should be balanced with transparency and patients’ ability to make informed choices. Private hospitals should explain substantial medication price increases and inform patients when more affordable equivalent alternatives are available.
Julia Yeo
